Education
About Us
Working with TipRanks
Follow Us
NeonMind Biosciences Inc (TSE:LCR)
:LCR
LCR Stock Chart & Stats
C$0.04
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.04
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.08
Previous CloseN/A
Volume126.00K
Average Volume (3M)290.69K
Market Cap
C$4.16M
Enterprise ValueC$3.64M
Total Cash (Recent Filing)C$206.03K
Total Debt (Recent Filing)C$1.14M
Price to Earnings (P/E)―
Beta0.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding92,499,870
10 Day Avg. Volume583,757
30 Day Avg. Volume290,695
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)-9.40
Price to Sales (P/S)0.00
P/FCF Ratio-6.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Reduced Cash Burn Vs Prior YearOperating cash burn improved materially versus 2024 (operating cash flow moved from roughly -1.13M to about -0.99M). This sustained reduction in cash outflow lengthens runway, reduces near-term financing frequency and reflects improving operational efficiency that supports stability over coming months.
Smaller Historical LossesLosses are materially smaller than the very large loss reported in 2021, indicating progress in cost control and operational discipline. While still loss-making, the trend toward smaller deficits is a durable sign management can tighten spending as the company advances development milestones.
Lean HeadcountA small workforce (28 employees) implies a lean cost structure and lower fixed overhead. That reduces monthly cash burn per employee, extending runway and providing flexibility to reallocate limited capital toward priority R&D or commercialization tasks over the next several quarters.
Bears Say
Pre-revenue BusinessThe company is pre-revenue with TTM revenue of 0 and persistent operating and net losses. Lack of commercial revenue means continued reliance on external financing and no demonstrated market traction, representing a fundamental execution and business-model risk across the next 2-6 months.
Negative Shareholder EquityNegative shareholders' equity (TTM ~ -0.64M) and debt meaningful relative to assets constrain financial flexibility and raise solvency concerns. This structural capitalization weakness limits borrowing capacity and heightens the risk that the company must seek dilutive financing to operate in the medium term.
Persistent Negative Cash FlowTTM operating and free cash flow are both around -0.99M, indicating ongoing cash burn. Persistent negative cash generation forces recurrent capital raises or other financing measures, which can dilute equity and constrain sustained investment in product development or commercialization over the coming months.
NeonMind Biosciences Inc News
LCR FAQ
What was NeonMind Biosciences Inc’s price range in the past 12 months?
NeonMind Biosciences Inc lowest stock price was C$0.01 and its highest was C$0.08 in the past 12 months.
What is NeonMind Biosciences Inc’s market cap?
NeonMind Biosciences Inc’s market cap is C$4.16M.
When is NeonMind Biosciences Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NeonMind Biosciences Inc’s earnings last quarter?
Currently, no data Available
Is NeonMind Biosciences Inc overvalued?
According to Wall Street analysts NeonMind Biosciences Inc’s price is currently Overvalued.
Does NeonMind Biosciences Inc pay dividends?
NeonMind Biosciences Inc does not currently pay dividends.
What is NeonMind Biosciences Inc’s EPS estimate?
NeonMind Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NeonMind Biosciences Inc have?
NeonMind Biosciences Inc has 92,499,870 shares outstanding.
What happened to NeonMind Biosciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NeonMind Biosciences Inc?
Currently, no hedge funds are holding shares in TSE:LCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NeonMind Biosciences Inc
Lancaster Resources Inc. engages in the acquisition, exploration, and development of mineral properties and renewable energy projects. It has option to acquire a 100% interest in the Alkali Flat lithium brine project situated in Lordsburg, New Mexico, the United States. The company is based in West Vancouver, Canada.
Technical Analysis
Options Prices
Currently, No data available
---